‘Organ-on-a-chip’ firm CN Bio has raised almost £17 million in the first close of its Series B fundraising round. The provider of single- and multi-organ microphysiological systems has secured the funding from several new investors, including £8m from Bayland Capital, and almost £4.5m from founding shareholder CN Innovations Holdings Ltd.  The investment will be used … Continue reading CN Bio raises £17m to expand organ-on-a-chip solutions